1. Home
  2. Regeneron Pharmaceuticals, Inc Patent Portfolio Statistics

Regeneron Pharmaceuticals, Inc Patent Portfolio Statistics

Regeneron Pharmaceuticals, Inc

Regeneron Pharmaceuticals, Inc`s Profile

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Regeneron Pharmaceuticals, Inc look like?

Total Applications: 18
Granted Patents: 7
Grant Index 87.5 %
Abandoned/Rejected Applications: 1 (12.5%)
In-Process Applications: 10
Average Grant Time: 1.74 Years
Average Office Actions: 0.86

Which Technology Area Regeneron Pharmaceuticals, Inc is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1632 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 5
1633 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 2
1646 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 2
1631 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1
1636 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 1

How many patents are Regeneron Pharmaceuticals, Inc filing every year?

Year Total Applications
2022 0*
2021 0*
2020 0
2019 14
2018 0

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Regeneron Pharmaceuticals, Inc in USPTO?

How are Regeneron Pharmaceuticals, Inc’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner